Capitainer’s qDBS dried blood spot system for home self-sampling proves 97% effective for clinical mass-testing of Covid-19 vaccine efficacy
Stockholm, Sweden April 13, 2021 – Swedish medtech start-up Capitainer today announced that Mikael Ström (PhD) has...
Västerbotten Region first to introduce home sampling for COVID-19 antibodies together with Capitainer
Stockholm, February 24, 2021: Swedish medtech start-up Capitainer today announced that the company’s modified qDBS dried...
Capitainer’s qDBS dried blood spot system for home sample collection employed in a nation-wide COVID-19 study in the US
Capitainer raises further SEK31 million to meet anticipated demand for qDBS dried blood spot sampling system as COVID-19 vaccine programs are rolled out
capitainer-awarded-iso-134852016-as-interest-grows-in-qdbs-testing-for-covid-19-and-other-challenging-applications/
capitainer-awarded-iso-134852016-as-interest-grows-in-qdbs-testing-for-covid-19-and-other-challenging-applications/
capitainer-awarded-iso-134852016-as-interest-grows-in-qdbs-testing-for-covid-19-and-other-challenging-applications/
capitainer-awarded-iso-134852016-as-interest-grows-in-qdbs-testing-for-covid-19-and-other-challenging-applications/
